FDA Inspection 1156950 — Admerus Biosciences, Pvt., Ltd.
The FDA completed an inspection of Admerus Biosciences, Pvt., Ltd. on October 29, 2021 in Hyderabad. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- October 29, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Hyderabad (India)
Additional Details
Clinical BA/BE